| Counterfeit drug prevention |
Products that are intentionally produced and faked the label of their identity to make it appear like real products. |
1, 7, 10, 11, 12, 13, 14, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27 |
| Product distribution |
Distributing the drugs to all participants with a supply chain, starting from the pharmaceutical industry to wholesalers, hospitals, or pharmacies. |
1, 5, 6, 7, 8, 9, 17 |
| Tracking & tracing |
Tracking all phases of drug production from manufacturer to consumer and quality assurance. |
1, 6, 11, 12, 16, 19, 20, 22, 24, 26, 27, 30, 32, 33, 34, 35 |
| Safety and security |
Protecting data from modification, deletion, and manipulation, and transmitting it safely and reliably throughout the network. |
1, 10, 25, 37, 38, 39, 40, 41 |
| Others |
Topics not covered by the category definitions, such as data governance, data quality, pharmaceutical turnover, and prescription drug monitoring. |
8, 9, 14, 22, 34, 42, 43, 44, 45, 46 |
| Others/Data governance |
Principles and practices that guarantee high quality throughout the entire data lifecycle. |
8, 22, 34, 42 |
| Others/Data quality |
An evaluation of the state of data based on accuracy, completeness, consistency, reliability, and whether it is up to date. |
8, 9, 14, 30, 43, 44 |
| Others/pharmaceutical turnover |
The volume of a metabolized or refined substance, usually within a specified period. |
45 |
| Others/Prescription drug monitoring |
Monitoring and documenting prescriptions of controlled substances. |
46 |
